Medpace Holdings, Inc. (MEDP)

404.03 +3.40 (+0.85%) At close: 04:00PM EDT

Medpace Holdings, Inc.

5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 5,800

Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Corporate governance

Medpace Holdings, Inc.’s ISS governance QualityScore as of 1 June 2024 is 7. The pillar scores are Audit: 5; Board: 9; Shareholder rights: 7; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.